Celyad Oncology SA (FRA:1C0)
Germany · Delayed Price · Currency is EUR 0.1500
+0.0025 (1.69%)
Last updated: Jan 9, 2026, 8:03 AM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €8.48 million as of January 9, 2026. Its market cap has decreased by -71.24% in one year.
Market Cap
8.48M
Enterprise Value
8.52M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.15
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 8.48M, a decrease of -91.68%. That is a compound annual growth rate of -18.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 8.48M | 11.47% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |